LIVN Profile
LivaNova PLC is a globally recognized medical device company dedicated to designing, developing, manufacturing, and distributing therapeutic solutions. The company operates through three distinct segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. In the Cardiopulmonary segment, LivaNova specializes in the development and distribution of a comprehensive range of cardiopulmonary products. These include oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connectors, and various other related products critical for cardiopulmonary procedures.
The Neuromodulation segment focuses on the design, development, and commercialization of the VNS Therapy System. This innovative implantable device delivers vagus nerve stimulation (VNS) therapy, primarily aimed at treating drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. Additionally, LivaNova is actively engaged in the development and clinical testing of the VITARIA System, intended for treating heart failure through VNS therapy. These pioneering solutions offer new hope for patients suffering from these challenging medical conditions.
The Advanced Circulatory Support segment of LivaNova is dedicated to the development, production, and distribution of temporary life support products. These products, including cardiopulmonary and respiratory support solutions, play a vital role in providing critical care to patients in need of advanced medical interventions. LivaNova serves a diverse range of healthcare professionals, including perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, medical institutions, and healthcare providers worldwide. With its commitment to innovation and collaboration, LivaNova continues to advance medical technology and improve patient outcomes.
|
